EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation

Alistair R Hines iD, Matthew Edgeworth, Paul W A Devine, Samuel Shepherd, Nicholas Chatterton, Claire Turner, Kathryn S Lilley iD, Xiaoyu Chen, Nicholas J Bond iD

Journal of the American Society for Mass Spectrometry · 2023

DOI: 10.1021/jasms.3c00037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2023. Verfasst von Alistair R Hines und 8 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Sciences, Biopharmaceutical Development R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immunoconjugates. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalImmunoconjugatesHumansChromatography, LiquidCysteineSulfhydryl CompoundsDisulfides

Stichwörter der Autor:innen

antibody intermediateantibody-drug conjugate (ADC)biologic manufacturing processesglycosylationmass spectrometry (MS)multi-attribute monitoring (MAM)site-specific conjugation

Substanzen

Antibodies, MonoclonalImmunoconjugatesCysteineSulfhydryl CompoundsDisulfides

Autor:innen und Institutionen

  • Analytical Sciences, Biopharmaceutical Development R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.
  • School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, MK7 6AA, United Kingdom.
  • College of Health, Medicine & Life Sciences, Brunel University London, Middlesex, UB8 3PH, United Kingdom.
  • Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QR, United Kingdom.
  • Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Gaithersburg, Maryland 20878, United States.

ORCID-Profile: Alistair R Hines, Kathryn S Lilley, Nicholas J Bond

Förderung

  • AstraZeneca

Zitieren

APA

Hines, A. R., Edgeworth, M., Devine, P. W. A., Shepherd, S., Chatterton, N., Turner, C., Lilley, K. S., Chen, X., & Bond, N. J. (2023). Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.3c00037

Vancouver

Hines AR, Edgeworth M, Devine PWA, Shepherd S, Chatterton N, Turner C, et al. Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation. Journal of the American Society for Mass Spectrometry. 2023. doi:10.1021/jasms.3c00037

BibTeX
@article{Hines2023,
  author = {Hines, Alistair R and Edgeworth, Matthew and Devine, Paul W A and Shepherd, Samuel and Chatterton, Nicholas and Turner, Claire and Lilley, Kathryn S and Chen, Xiaoyu and Bond, Nicholas J},
  title = {Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2023},
  doi = {10.1021/jasms.3c00037}
}
Kostenlos starten →